InvitroCue and TissueGnostics Team Up to Provide Image Analysis Services in Asia
Singapore and Vienna/Austria, June 10, 2015 (Newswire.com) - InvitroCue, a Singapore based provider of products and services for in vitro DMPK, in vitro toxicology and digital pathology, and TissueGnostics, a developer of image acquisition and image cytometry instruments based in Vienna, have signed a term sheet to promote an jointly offer their solutions in Singapore and other Asian countries.
TissueGnostics has been a trend-setter for automated analysis of histological tissue sections by introducing its TissueFAXS™ Cytometry technology more than 10 years ago. The high quality of the analytical solutions offered is reflected by some 250 scientific reference papers, a majority of which being published in high-ranking and top journals. With its 5th generation of image cytometry software TissueGnostics has now introduced the concept of “Tissue Sociology”, which is a novel concept to look at cellular interactions on a quantitative/cytometric basis.
InvitroCue provides, amongst other things, services in the field of digital pathology, ranging from histology services to image analysis and pathology review. The company will leverage on TissueGnostics’ state-of-the-art analysis tools as part of its image analysis service offerings. Thereby, customers benefit both from TissueGnostics’ powerful software, and the experience and know-how of InvitroCue’s image analysis specialists.
“The collaboration with InvitroCue means a great step forward in our global expansion strategy, in which Asia plays a key role. The partnership with InvitroCue will significantly expand our presence in this market,” said Dr Rupert Ecker, Co-Founder and Managing Director of TissueGnostics.
“We are very happy to announce that TissueGnostics chose InvitroCue as a partner for Singapore and Asia. We know the Asian market intimately and understand the needs of our customers. We aim to be the leading image analysis service provider in the Asian region for those organisations. With TissueGnostics, we have the right tools and the right partner at our side,” said Dr Steven Fang, Founder and Managing Director of InvitroCue.
About InvitroCue
InvitroCue provides innovative products and services in the fields of in vitro DMPK, in vitro toxicology and digital pathology utilizing cell-based models and image analysis tools. InvitroCue's technologies and assays have been developed and validated together with renowned leading pharmaceutical companies and scientific collaborators. The company currently owns several 3D in vitro cell culture models for long-term hepatocyte culture and various image analysis tools for automated quantification of cells and tissue. InvitroCue uses these technologies and assays to support better decision making in preclinical studies, clinical trials and diagnostics. Its solutions can be applied in the realms of drug testing as well as research and development of cosmeceuticals and medical devices.
InvitroCue was established in 2012 as a spin-off from A*STAR and is headquartered in Singapore.
Visit http://www.invitrocue.com/
About TissueGnostics
TissueGnostics, founded in 2003, is an ISO 13485-certified manufacturer of laboratory instruments and has been developing In-Vitro Diagnostics (IVD)-compliant, state-of-the-art products for computer-controlled scanning and image analysis of microscopic specimens. Our products are dedicated to the automated analysis of histological samples and cell cultures (TissueFAXS™) as well as blood smears (HemoFAXS™) and comprise full scanning systems for brightfield and/or fluorescence samples, live-cell imaging and high-throughput instruments as well as software for image cytometry. TissueGnostics’ unique analysis technology and solutions are used in medical research, clinical studies, as well as routine diagnostics by universities, hospitals, and the pharmaceutical as well as cosmetics industry in currently 28 countries on 6 continents. TissueGnostics has been involved in various international research collaborations, including EU-funded projects/training networks on digital pathology, personalized medicine, stem cell therapeutics, and translational oncology.
Visit http://www.tissuegnostics.com